MaxCyte, Inc.MXCTNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-1x
Contraction
Streak
4 yr
Consecutive declineDecelerating
PeriodValue
2025-16.53%
2024-1.21%
202328.24%
202240.42%
2021101.79%
202017.09%
201911.66%
201813.94%
201717.24%
201649.53%